TrialAnnals of the rheumatic diseases2017

Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.